Istituto Biochimico Italiano S.p.A. Company Profile

20:14 EDT 19th September 2018 | BioPortfolio

The Istituto Biochimico Italiano – IBI - founded in 1919 by Prof. Giovanni Lorenzini, is a pharmaceutical Company with a significant scientific tradition, present on the national and international markets since more than 80 years.Since 60 years the Company is managed by female managers. When the founder died, his daughter Loredana Lorenzini took over. She was the grandmother of the actual President Camilla Borghese, who is running the Company since the late 90ies.


Via di Fossignano, 2


Fax: 39.06921506

News Articles [4 Associated News Articles listed on BioPortfolio]

Il maestro dei colori Francisco Conti collabora con la cinese Lionking per aprire l'Istituto ...

ZIBO, Cina, 2 aprile 2018 /PRNewswire/ -- Recentemente il maestro italiano dei colori Conti ha stipulato un contratto con ...

Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)

Energica: Sorprendente primer trimestre de 2018, tras un intenso 2017

Energica Motor Company S.p.A., fabricante italiano de motocicletas eléctricas de alto rendimiento, cerró el primer trimestre de 2018 con un libro de pedidos corrientes que Read more...

Platelet BioGenesis Appoints Leading Hematology Experts and Physicians to Its Scientific Advisory Board

Platelet BioGenesis, the leader in the production of functional human platelets (PLTs+TM) from stem cells and the development of platelet-based therapeutics, announced it has recr...

Drugs and Medications [0 Results]


Clinical Trials [10 Associated Clinical Trials listed on BioPortfolio]

Cancer Anesthesia and Frailty

Subjects undergoing cancer related surgery at the Fondazione IRCCS Istituto Nazionale dei Tumori - Milano will be consecutively recruited. Data regarding presence of co-morbidities, frailt...

Italian Registry on Unprotected Left Main

The RITMO (Registro Italiano sul trattamento del Tronco coMune non protettO) observational study will appraise the prevalence, management strategy, and prognosis of unprotected left main c...

Post Operative Cognitive Dysfunction

The objective of this study will be to estimate the incidence of postoperative cognitive dysfunction (DCPO) in patients over 65 years of age, undergoing surgical / anesthetic procedures an...

Gonadal Toxicity in Women With Hodgkin Lymphoma

The Gruppo Italiano Studio Linfomi has been collecting data on patients with Hodgkin Lymphoma (HL) since 1988. This archive represents a homogeneous series of consecutive patients with HL....

Early Chemotherapy Intensification in Interim-Positron Emission Tomography (PET) Positive Hodgkin Lymphoma

Early interim-PET after two courses of chemotherapy is a powerful outcome predictor in advanced-stage Hodgkin Lymphoma (HL) patients treated with adriamycin (doxorubicin), bleomycin, vin...

Companies [4 Associated Companies listed on BioPortfolio]

Istituto Biochimico Italiano S.p.A.

The Istituto Biochimico Italiano – IBI - founded in 1919 by Prof. Giovanni Lorenzini, is a pharmaceutical Company with a significant scientific tradition, present on the national and international m...

Abiogen Pharma S.p.a

It may seem presumptuous to mention tradition when talking about a company that passed its first budget in 1997. In reality, very few Italian companies can claim a similar experience in the chemical-p...

Istituto Superiore di Sanità

The Istituto Superiore di Sanità (ISS) is the leading technical and scientific public body of the Italian National Health Service. Its activities include research, control, training and consultation ...

Italian Institute for Foreign Trade

The Italian Institute for Foreign Trade (I.C.E., Istituto nazionale per il Commercio Estero) is the Italian government agency entrusted with the promotion of trade, business opportunities and industri...

More Information about "Istituto Biochimico Italiano S.p.A." on BioPortfolio

We have published hundreds of Istituto Biochimico Italiano S.p.A. news stories on BioPortfolio along with dozens of Istituto Biochimico Italiano S.p.A. Clinical Trials and PubMed Articles about Istituto Biochimico Italiano S.p.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Istituto Biochimico Italiano S.p.A. Companies in our database. You can also find out about relevant Istituto Biochimico Italiano S.p.A. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record